VitaVitro was honoured to participate in the 31st Annual Scientific Meeting of the Middle East Fertility Society (MEFS), held from November 21–23, 2024, in Doha, Qatar. The conference brought together leading experts in the field of reproductive medicine, providing a valuable platform for sharing the latest research and fostering international collaboration.
During the event, VitaVitro showcased its advanced vitrification technology and comprehensive product line, which garnered significant attention from attending experts. Through in-depth discussions with reproductive centres and industry leaders from the Middle East, VitaVitro deepened its relationships with regional partners and explored future collaboration opportunities. The conference not only highlighted the company’s innovative technologies in reproductive medicine but also offered a key opportunity to further develop and expand its presence in the Middle East market.
In August 2024, VitaVitro successfully won the public procurement bid for the Saudi Arabian Ministry of Health's National Unified Procurement Company (NUPCO) for the 2025–2027 period, securing its place as the exclusive supplier of vitrification and thawing solutions for public reproductive centres. This achievement further consolidates VitaVitro’s strategic position in the Middle East market and sets the stage for the implementation of additional international projects over the next three years.
By participating in MEFS, VitaVitro not only demonstrated its technological capabilities but also reinforced its commitment to advancing international collaborations in the field. Moving forward, VitaVitro will continue to focus on driving innovation and expanding its global footprint, providing high-quality products and services to reproductive centres around the world.